Powering the Life Sciences Lifecycle with Orchestrated Intelligence
Backed by decades of expertise, our end-to-end platform enables you to synchronize your ecosystem from discovery to delivery.
Embedded AI sharpens insights, enabling faster, data-driven decisions and accelerating your therapy development from early research through commercialization.
Dassault Systèmes Life Science & Healthcare
Medidata is part of Dassault Systèmes, the global leader in virtual twin technology, with deep knowledge and knowhow across highly regulated industries including aerospace, automotive, advanced manufacturing, where precision demands safety and performance.
When you work with Medidata, the same virtual twin science transforms your life sciences—modeling, predicting, and optimizing outcomes before they happen.
of medical devices designed in our platform
of new molecular entities designed and developed
of all FDA novel drug launches in 2025
of FDA novel drug approvals in Oncology, Immunology, and Respiratory in 2025
Virtual Worlds for Real Life
Connecting the virtual and real worlds enables a continuous flow of data and insights to drive real-life progress and innovation.
WHAT OTHER PROVIDERS DO
Most clinical technology providers focus solely on trial execution.
Your clinical development lives within Dassault Systèmes’ global systems architecture.
Most platforms manage data.
Model behavior across the discovery, trial, and production lifecycle.
Data access and analysis are episodic and fragmented across tools.
Insight becomes continuous.
Action on outliers and diversions is prompted by alerts and is reactive.
Risk becomes predictive.
Most AI analyzes historical datasets.
Trust predictive modeling within live workflows, while decisions still matter.
Most end-to-end drug development requires a multi-system approach.
Intelligence scales across discovery, trials, and production.
WHY THE 3DS PLATFORM IS FUNDAMENTALLY DIFFERENT
Why This Platform Is Fundamentally Different
Serving the Life Sciences Industry
Bridging Knowledge, Speed, and Quality
Reimagining for Quality
INDUSTRY RECOGNITION
Dassault Systèmes wins 2025 Innovation Award from Frost & Sullivan for outstanding achievements in digital innovation, strategic execution, and customer-centric transformation in smart manufacturing for the Life Sciences & Healthcare industry.
Patient-centric Technologies for Faster Medical Breakthroughs
Innovations That Turn the Virtual into Reality
See how working in unison accelerates life-changing therapies for patients everywhere.
Apply Clinical Data in Design & Development
Read how Phillips optimizes its studies and improves product design quality by efficiently integrating vast amounts of data.
Meet the Growing Demand for Innovative Biologics
Transform R&D, accelerate timelines, and improve efficiency with digital and AI solutions.
Cell & Gene Therapy (CGT) Development
Deliver safer patient outcomes with quality control and assurance across the PML.
CAR-T Treatment for Blood Cancers
Power new drug development with pre-clinical scientific expertise and the largest patient-level historical clinical trial dataset in the world.
Virtual Modeling and AI Enable MedTech In Silico Clinical Trials
Better predict efficacy and safety by implementing virtual twin technology for simulation-driven in silico trials.